LC
TMDX icon

Lindbrook Capital’s Transmedics TMDX Stock Holding History

Lindbrook Capital’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$184K Buy
2,742
+1,122
+69% +$77.2K 0.02% 443
2024
Q4 		$101K Buy
1,620
+1,205
+290% +$112K 0.01% 557
2024
Q3 		$65.2K Sell
415
-8
-2% -$1.23K 0.01% 704
2024
Q2 		$63.7K Buy
423
+31
+8% +$3.72K 0.01% 702
2024
Q1 		$29K Buy
392
+56
+17% +$4.62K ﹤0.01% 1025
2023
Q4 		$26.5K Sell
336
-175
-34% -$10.6K ﹤0.01% 1034
2023
Q3 		$28K Buy
511
+180
+54% +$13K ﹤0.01% 902
2023
Q2 		$27.8K Sell
331
-8
-2% -$612 ﹤0.01% 931
2023
Q1 		$25.7K Buy
339
+1
+0.3% +$69 ﹤0.01% 952
2022
Q4 		$20.9K Buy
338
+8
+2% +$425 ﹤0.01% 1038
2022
Q3 		$14K Buy
330
+12
+4% +$522 ﹤0.01% 1181
2022
Q2 		$10K Buy
318
+7
+2% +$187 ﹤0.01% 1269
2022
Q1 		$8K Buy
311
+86
+38% +$1.54K ﹤0.01% 1403
2021
Q4 		$4K Hold
225
– – ﹤0.01% 1611
2021
Q3 		$7K Hold
225
– – ﹤0.01% 1148
2021
Q2 		$7K Hold
225
– – ﹤0.01% 1210
2021
Q1 		$9K Buy
+225
New +$6.92K ﹤0.01% 1071

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lindbrook Capital's TMDX Position: Q1 2025 in Review

Lindbrook Capital increased its Transmedics (TMDX) stake by 69% in Q1 2025, buying an estimated $77.2K and bringing the position to 2,742 shares worth $184K. The position accounts for 0.02% of the portfolio, ranked #443.

Lindbrook Capital first reported a position in TMDX in Q1 2021 and has held it in 17 quarters since. 299 funds tracked by Wall St. Rank hold TMDX as of Q1 2025.

  • Lindbrook Capital held 2,742 shares of Transmedics worth $184K as of Q1 2025.
  • Lindbrook Capital bought 1,122 Transmedics shares in Q1 2025, an estimated $77.2K.
  • Transmedics made up 0.02% of Lindbrook Capital's portfolio in Q1 2025, its #443 holding.
  • Lindbrook Capital first reported a position in Transmedics in Q1 2021 and has held it in 17 quarters since.
  • 299 funds tracked by Wall St. Rank held Transmedics as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.